Your browser doesn't support javascript.
loading
Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience.
Atalar, Banu; Ozsahin, Mahmut; Call, Jason; Napieralska, Aleksandra; Kamer, Serra; Villa, Salvador; Erpolat, Petek; Negretti, Laura; Lassen-Ramshad, Yasmin; Onal, Cem; Akyurek, Serap; Ugurluer, Gamze; Baumert, Brigitta G; Servagi-Vernat, Stephanie; Miller, Robert C; Ozyar, Enis; Sio, Terence T.
Afiliação
  • Atalar B; Department of Radiation Oncology, Acibadem University, Istanbul, Turkey. Electronic address: banu.atalar@acibadem.com.tr.
  • Ozsahin M; Centre Hospitalier Universitaire Vaudois (CHUV), Department of Radiation Oncology, Lausanne, Switzerland.
  • Call J; Department of Radiation Oncology, Mayo Clinic Hospital, Phoenix, AZ, United States.
  • Napieralska A; Radiotherapy Department, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Poland.
  • Kamer S; Department of Radiation Oncology, Ege University, Izmir, Turkey.
  • Villa S; Radiation Oncology, Catalan Institute of Oncology, Badalona, Catalonia, Spain.
  • Erpolat P; Department of Radiation Oncology, Gazi University, Ankara, Turkey.
  • Negretti L; Centre Hospitalier Universitaire Vaudois (CHUV), Department of Radiation Oncology, Lausanne, Switzerland.
  • Lassen-Ramshad Y; Oncological Department, Aarhus University Hospital, Denmark.
  • Onal C; Department of Radiation Oncology, Baskent University, Adana, Turkey.
  • Akyurek S; Department of Radiation Oncology, Ankara University, Ankara, Turkey.
  • Ugurluer G; Department of Radiation Oncology, Acibadem University, Istanbul, Turkey.
  • Baumert BG; Depts. Radiation Oncology (MAASTRO), GROW, Maastricht University MC, Netherlands; Paracelsus Klinik Osnabrueck and University of Muenster, University Bonn MC, Germany.
  • Servagi-Vernat S; Radiation Oncology, University Hospital of Besancon, France.
  • Miller RC; Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL, United States.
  • Ozyar E; Department of Radiation Oncology, Acibadem University, Istanbul, Turkey.
  • Sio TT; Department of Radiation Oncology, Mayo Clinic Hospital, Phoenix, AZ, United States.
Radiother Oncol ; 127(1): 96-102, 2018 Apr.
Article em En | MEDLINE | ID: mdl-29373196

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Cerebelares / Meduloblastoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte / Europa Idioma: En Revista: Radiother Oncol Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Cerebelares / Meduloblastoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte / Europa Idioma: En Revista: Radiother Oncol Ano de publicação: 2018 Tipo de documento: Article